Literature DB >> 1320130

Phase II trials in small-cell lung cancer: shouldn't we be doing better?

S C Grant, M G Kris.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1320130     DOI： 10.1093/jnci/84.14.1058

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  1 in total

1.  Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer. A Southwest Oncology Group study.

Authors:  S K Williamson; J Crowley; R B Livingston; G Weiss
Journal:  Invest New Drugs       Date:  1993-02       Impact factor: 3.850
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.